Guillaume HERLEM

Prof. Dr. Guillaume HERLEM

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2004 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
Boris LakardBoris Lakard
Boris Lakard
Guillaume HERLEMGuillaume HERLEM
Guillaume HERLEM
SLSophie Lakard
Sophie Lakard
AAAlexandros Antoniou
Alexandros Antoniou
BFBernard Fahys
Bernard Fahys

10 February 2017 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
FDFlorent Dufour
Florent Dufour
TRThibault Rattier
Thibault Rattier
SSSarah Shirley
Sarah Shirley
GPGaelle Picarda
Gaelle Picarda
ACAndrei Alexandru Constantinescu
Andrei Alexandru Constantinescu
OMOlivier Micheau
Olivier Micheau
APO2L/TRAIL (TNF-related apoptosis-inducing ligand) induces death of tumor cells through two agonist receptors, TRAIL-R1 and TRAIL-R2. We demonstrate here that N-linked glycosylation (N-glyc) plays also an important regulatory role for TRAIL-R1-mediated and mouse TRAIL receptor (mTRAIL-R)-mediated apoptosis, but not for TRAIL-R2, which is devoid of N-glycans. Cells expressing N-glyc-defective mutants of TRAIL-R1 and mouse TRAIL-R were less sensitive to TRAIL than their wild-type counterparts. Defective apoptotic signaling by N-glyc-deficient TRAIL receptors was associated with lower TRAIL receptor aggregation and reduced DISC formation, but not with reduced TRAIL-binding affinity. Our results also indicate that TRAIL receptor N-glyc impacts immune evasion strategies. The cytomegalovirus (CMV) UL141 protein, which restricts cell-surface expression of human TRAIL death receptors, binds with significant higher affinity TRAIL-R1 lacking N-glyc, suggesting that this sugar modification may have evolved as a counterstrategy to prevent receptor inhibition by UL141. Altogether our findings demonstrate that N-glyc of TRAIL-R1 promotes TRAIL signaling and restricts virus-mediated inhibition.

1 March 2007 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
Boris LakardBoris Lakard
Boris Lakard
OSOlivier Segut
Olivier Segut
SLSophie Lakard
Sophie Lakard
Guillaume HERLEMGuillaume HERLEM
Guillaume HERLEM
TGTijani Gharbi
Tijani Gharbi

1 April 2004 in Bioelectrochemistry
Verified
Journal Article
Closed access
SLS Lakard
S Lakard
Guillaume HERLEMGuillaume HERLEM
Guillaume HERLEM
APA Propper
A Propper
AKA Kastner
A Kastner
GMG Michel
G Michel
BFB Fahys
B Fahys

13 January 2015 in Nano Letters
Verified
Journal Article
Closed access
AZAl Batoul Zakaria
Al Batoul Zakaria
Fabien PicaudFabien Picaud
Fabien Picaud
TRThibault Rattier
Thibault Rattier
MPMarc Pudlo
Marc Pudlo
LSLucien Saviot
Lucien Saviot
Guillaume HERLEMGuillaume HERLEM
Guillaume HERLEM

14 September 2021 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
PDF file
YRYaëlle Roina
Yaëlle Roina
FAFrédéric Auber
Frédéric Auber
DHDidier Hocquet
Didier Hocquet
Guillaume HERLEMGuillaume HERLEM
Guillaume HERLEM